Chris Gibson
North America, Utah, United States, Salt Lake City
Description
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Direc...
Investor Profile
Chris Gibson has backed more than 11 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, United Kingdom.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Series A (55%)
- Seed (36%)
- Series Unknown (9%)
Country Focus
- United States (64%)
- Switzerland (9%)
- United Kingdom (9%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- France (9%)
- Germany (9%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Artificial Intelligence (Ai)
- Therapeutics
- Machine Learning
- Life Science
- Medical
- Financial Services
- Loyalty Programs
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
